Your browser doesn't support javascript.
loading
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.
Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Dotti, Gianpietro; Sangiolo, Dario.
Afiliação
  • Leuci V; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Donini C; Department of Oncology, University of Torino, Turin, Italy.
  • Grignani G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Rotolo R; Department of Oncology, University of Torino, Turin, Italy.
  • Mesiano G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Fiorino E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Gammaitoni L; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • D'Ambrosio L; Department of Oncology, University of Torino, Turin, Italy.
  • Merlini A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Landoni E; Department of Oncology, University of Torino, Turin, Italy.
  • Medico E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Capellero S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Giraudo L; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Cattaneo G; Department of Oncology, University of Torino, Turin, Italy.
  • Iaia I; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Pignochino Y; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Basiricò M; Department of Oncology, University of Torino, Turin, Italy.
  • Vigna E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Pisacane A; Department of Oncology, University of Torino, Turin, Italy.
  • Fagioli F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Ferrone S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Aglietta M; Department of Oncology, University of Torino, Turin, Italy.
  • Dotti G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Sangiolo D; Department of Oncology, University of Torino, Turin, Italy.
Clin Cancer Res ; 26(23): 6321-6334, 2020 12 01.
Article em En | MEDLINE | ID: mdl-32900797
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoglicanas de Sulfatos de Condroitina / Sarcoma / Linfócitos / Imunoterapia Adotiva / Células Matadoras Induzidas por Citocinas / Receptores de Antígenos Quiméricos / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoglicanas de Sulfatos de Condroitina / Sarcoma / Linfócitos / Imunoterapia Adotiva / Células Matadoras Induzidas por Citocinas / Receptores de Antígenos Quiméricos / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article